Journal Article

Protecting Privacy and Transforming COVID-19 Case Surveillance Datasets for Public Use

Dupervil, Brandi, Pollock, Dan, Weber, J. Todd, Bottichio, Lyndsay, Price, Jason, Soroka, Stephen, Sweeney, Patricia, Fuld, Jennifer, Lee, Brian, Silk, Benjamin, Deputy, Nicholas P., Duck, Wil

2021

Overview

Objectives Federal open-data initiatives that promote increased sharing of federally collected data are important for transparency, data quality, trust, and relationships with the public and state, tribal, local, and territorial partners. These initiatives advance understanding of health conditions and diseases by providing data to researchers, scientists, and policymakers for analysis, collaboration, and use outside the Centers for Disease Control and Prevention (CDC), particularly for emerging conditions such as COVID-19, for which data needs are constantly evolving. Since the beginning of the pandemic, CDC has collected person-level, de-identified data from jurisdictions and currently has more than 8 million records. We describe how CDC designed and produces 2 de-identified public datasets from these collected data. Methods We included data elements based on usefulness, public request, and privacy implications; we suppressed some field values to reduce the risk of re-identification and exposure of confidential information. We created datasets and verified them for privacy and confidentiality by using data management platform analytic tools and R scripts. Results Unrestricted data are available to the public through Data.CDC.gov, and restricted data, with additional fields, are available with a data-use agreement through a private repository on GitHub.com. Practice Implications Enriched understanding of the available public data, the methods used to create these data, and the algorithms used to protect the privacy of de-identified people allow for improved data use. Automating data-generation procedures improves the volume and timeliness of sharing data.

• Publisher: SAGE Publications,SAGE PUBLICATIONS, INC
• Subject: Algorithms / Confidentiality / Coronaviruses / COVID-19 / Data collection / Data management / Data quality / Datasets / Disease control / Disease prevention / Health initiatives / Pandemics / Policy making / Prevention / Privacy / Public health / Public Health Methodology / Public use / Risk reduction / Scripts / Severe acute respiratory syndrome coronavirus 2 / Surveillance / Transparency / Usefulness